CT-208 Efficacy of Axatilimab in the Management of Refractory Chronic Graft-Versus-Host Disease
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01748-8
M
Muhammad Jawad Javed
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
3
Citations
1
h-index
0
i10-index
Muhammad Jawad Javed is an academic researcher from Michigan Cancer Research Consortium. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Acute Myeloid Leukemia Research & Hematopoietic Stem Cell Transplantation. The author has an h-index of 1, co-authored 11 publications.
Papers by this author
worksEfficacy of Axatilimab in the Management of Refractory Chronic Graft-Versus-Host Disease
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01033-4
Impact of Minimal Residual Disease Status on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
2025 · Transplantation and Cellular Therapy · 0 citations
https://doi.org/10.1016/j.jtct.2025.01.192
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat